Doximity, Inc.(DOCS)

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Latest News & Analysis
Doximity (DOCS): Q3 Earnings, AI Strategy, and Market Outlook
Doximity (DOCS) balances growth with challenges in 2025, including a fiduciary duty investigation and valuation concerns. This analysis offers a comprehensive market outlook.
Doximity (DOCS): Q3 Earnings, AI Growth, and Market Outlook
Doximity (DOCS) exhibits strong Q3 2025 earnings, driven by AI and advertising growth, and telehealth leadership. Concerns exist regarding valuation and a legal investigation.
Doximity, Inc. Announces Major Business Developments
Doximity, Inc. (DOCS) is navigating a landscape of growth opportunities and industry challenges, with a focus on AI and telehealth. This analysis dives into the details.
Doximity (DOCS): Growth, Legal Risks, and Future Outlook
Analysis of Doximity's growth, legal risks, and strategic moves in healthcare information. A data-driven look at DOCS's opportunities and challenges.
Doximity (DOCS): AI-Driven Growth Meets Legal Headwinds
Doximity Inc. navigates impressive financial growth, fueled by AI innovation, amidst escalating legal challenges and a dynamic telehealth market.
Doximity (DOCS): Legal Challenges & AI-Driven Growth Analysis
Doximity faces legal scrutiny and shareholder lawsuits despite robust AI-driven growth. We analyze its strategic innovations, financial resilience, and market position.
Doximity (DOCS) Analysis: FY2025 Growth, AI, and Legal Headwinds
Explore Doximity's latest financial results, strategic AI integration, and ongoing legal challenges impacting its market position and growth trajectory in 2025.
Doximity (DOCS): AI-Driven Growth Amidst Shareholder Litigation
Doximity's latest financial results reveal robust growth, with net income surging by +51.23% year-over-year, alongside a strategic pivot towards AI and enterprise solutions.
Doximity, Inc. (DOCS) AI Growth and Financial Strength Amid Shareholder Litigation
Doximity's strategic AI pivot fuels revenue growth and enterprise expansion, while strong financials support resilience amid shareholder litigation risks.
Doximity, Inc. Financial & Strategic Update: AI Growth, Legal Challenges, and Market Positioning
Explore Doximity's robust AI-driven revenue growth, strategic enterprise expansion, legal headwinds, and financial metrics shaping its market stance in digital health.
Doximity, Inc. Latest Financials and Legal Challenges: AI Growth Amid Litigation
Doximity posts strong FY2025 results with 20% revenue growth and robust AI adoption despite shareholder litigation risks impacting valuation.
Doximity Inc. Latest Corporate Update: Litigation, AI Growth & Financial Strength Insights
Doximity navigates shareholder litigation amid strong AI-driven growth and robust financials, maintaining competitive edge in healthcare IT.
Doximity, Inc. (DOCS) Market Update: Q1 FY26 Earnings, AI Growth, and Legal Risks
Doximity's latest Q1 FY26 earnings preview, AI integration, revenue growth drivers, and shareholder litigation outline key investor considerations.
Doximity, Inc. (DOCS) Market Surge and Strategic Financial Performance Analysis
Doximity, Inc. (DOCS) stock jumps +11.75% amid strong earnings beats and robust financial metrics, reflecting strategic growth and solid market positioning.
Doximity (DOCS): Margin Surge, Cash Flow Strength and Valuation Tension
Doximity posted **FY2025 revenue $570.4M (+19.98%)** and **FCF $266.7M (≈46.8% margin)** — strong cash conversion but trading at a premium that hinges on AI monetization.
Doximity (DOCS): Q1 Beat, $63M AI Push and Litigation That Won’t Fade
Doximity reported Q1 revenue of $145.9M (+15.00%), raised FY revenue to $628–$636M and closed a $63M AI tuck‑in — even as class‑action litigation advances into discovery.